Investing.com - Alexion (NASDAQ:ALXN) reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Alexion announced earnings per share of $3.24 on revenue of $1.59B. Analysts polled by Investing.com anticipated EPS of $2.59 on revenue of $1.42B.
Alexion shares are up 6.2% from the beginning of the year, still down 10.67% from its 52 week high of $128.57 set on October 9. They are under-performing the Nasdaq 100 which is up 27.59% from the start of the year.
Alexion follows other major Healthcare sector earnings this month
Alexion's report follows an earnings beat by J&J on October 13, who reported EPS of $2.2 on revenue of $21.08B, compared to forecasts EPS of $1.98 on revenue of $20.2B.
Pfizer had beat expectations on Tuesday with third quarter EPS of $0.72 on revenue of $12.13B, compared to forecast for EPS of $0.69 on revenue of $12.31B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar